revakinagene taroretcel-lwey 440000 CELLS Drug Implant

RxNorm concept 2708837, clinical drug (scd). Prescribable name: revakinagene taroretcel-lwey 200,000 to 440,000 CELLS Intravitreal Implant.

RxCUI: 2708837
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2708837 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

revakinagene taroretcel 2708830

Other names

revakinagene taroretcel-lwey 200,000 to 440,000 CELLS Intravitreal Implant

Related concepts

revakinagene taroretcel-lwey 440000 CELLS (SCDC, consists of)
Drug Implant (DF, has dose form)
revakinagene taroretcel-lwey 440000 CELLS Drug Implant [Encelto] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2708837 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2708837 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2708837. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.